Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03451058 · ClinicalTrials.gov registry record
Integrated Eye Tracking and Neural Monitoring for TBI: Optimization
A clinical trial, sponsored by United States Naval Medical Center, San Diego.
- Completed
- Registry status
- 138
- Enrollment target
NCT03451058: Completed study, sponsored by United States Naval Medical Center, San Diego.
NCT03451058 is a clinical trial that has completed, run by United States Naval Medical Center, San Diego. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03451058 has completed, sponsored by United States Naval Medical Center, San Diego.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
Traumatic brain injury (TBI) is one of the most frequent injuries affecting service members. Unfortunately, current neurocognitive assessment tools are unable to reliably detect mild TBI more than a few days post- injury. Therefore, development of advanced systems for assessment and diagnosis of TBI are a top priority within Department of Defense. This project aims to evaluate a combined electroencephalography (EEG) and eye tracking system capable of assessing compromised cognitive function stemming from TBI, with the goal of enhancing operational readiness and aiding in diagnosis, improving health care and rehabilitation for affected military personnel.
Primary Outcome
Spectral features and event related responses collected from scalp measurements during performance of an eye movement and working memory task.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2017-07-07 |
| Est. Completion | 2021-12-31 |
What the finished NCT03451058 record still lists
NCT03451058 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03451058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03451058 about?
NCT03451058 is a clinical study titled "Integrated Eye Tracking and Neural Monitoring for TBI: Optimization". Traumatic brain injury (TBI) is one of the most frequent injuries affecting service members. Unfortunately, current neurocognitive assessment tools are unable to reliably detect mild TBI more than a few days post- injury. Therefore, development of advanced systems for assessment and diagnosis of TBI...
What is the current status of trial NCT03451058?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2017-07-07. Estimated completion is 2021-12-31.
Who is sponsoring clinical trial NCT03451058?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI